Back to today’s briefing

Story perspectives

Xilio Therapeutics Grants 26,000 Stock Options to New Hires

10/4/2025

34 7

Summary

Story summary

Xilio Therapeutics, Inc. granted 26,000 non-qualified stock options to three new employees, effective Oct 1, 2025.
The options have a ten-year term with 25% vesting after one year and 75% vesting monthly over three years. The exercise price is $0.8326 per share.
The grant aligns with Xilio's 2022 Inducement Stock Incentive Plan and Nasdaq Listing Rule 5635(c)(4).

1 of 1

Story summary

Xilio Therapeutics, Inc. granted 26,000 non-qualified stock options to three new employees, effective Oct 1, 2025.
The options have a ten-year term with 25% vesting after one year and 75% vesting monthly over three years. The exercise price is $0.8326 per share.
The grant aligns with Xilio's 2022 Inducement Stock Incentive Plan and Nasdaq Listing Rule 5635(c)(4).